These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

460 related items for PubMed ID: 8613929

  • 21. Neuropharmacological profile of MD 780515, a new reversible inhibitor of type A monoamine oxidase.
    Jalfre M, Bucher B, Coston A, Mocquet G, Porsolt RD.
    Arch Int Pharmacodyn Ther; 1982 Oct; 259(2):194-221. PubMed ID: 6129835
    [Abstract] [Full Text] [Related]

  • 22. Pharmacologic profile of fezolamine fumarate: a nontricyclic antidepressant in animal models.
    Baizman ER, Ezrin AM, Ferrari RA, Luttinger D.
    J Pharmacol Exp Ther; 1987 Oct; 243(1):40-54. PubMed ID: 3668867
    [Abstract] [Full Text] [Related]

  • 23. Pressor effect of oral tyramine during treatment with befloxatone, a new reversible monoamine oxidase-A inhibitor, in healthy subjects.
    Patat A, Berlin I, Durrieu G, Armand P, Fitoussi S, Molinier P, Caille P.
    J Clin Pharmacol; 1995 Jun; 35(6):633-43. PubMed ID: 7665725
    [Abstract] [Full Text] [Related]

  • 24. Extracts of Valeriana officinalis L. s.l. show anxiolytic and antidepressant effects but neither sedative nor myorelaxant properties.
    Hattesohl M, Feistel B, Sievers H, Lehnfeld R, Hegger M, Winterhoff H.
    Phytomedicine; 2008 Jan; 15(1-2):2-15. PubMed ID: 18160026
    [Abstract] [Full Text] [Related]

  • 25. A 2-amino-2-oxazoline derivative as an antidepressant in mice.
    Bourin M, Creuzet MH, Jarry C, Colombel MC.
    Arzneimittelforschung; 1988 May; 38(5):666-8. PubMed ID: 3261982
    [Abstract] [Full Text] [Related]

  • 26. Monoamine oxidase-A inhibitors and dopamine metabolism in rat caudatus: evidence that an increased cytosolic level of dopamine displaces reversible monoamine oxidase-A inhibitors in vivo.
    Colzi A, D'Agostini F, Cesura AM, Borroni E, Da Prada M.
    J Pharmacol Exp Ther; 1993 Apr; 265(1):103-11. PubMed ID: 8473998
    [Abstract] [Full Text] [Related]

  • 27. Investigating potential anxiolytic, antidepressant and memory enhancing activity of deprenyl.
    Nowakowska E, Kus K, Chodera A, Rybakowski J.
    J Physiol Pharmacol; 2001 Dec; 52(4 Pt 2):863-73. PubMed ID: 11785779
    [Abstract] [Full Text] [Related]

  • 28. Ranbezolid, a novel oxazolidinone antibacterial: in vivo characterisation of monoamine oxidase inhibitory potential in conscious rats.
    Naruganahalli KS, Shirumalla RK, Bansal V, Gupta JB, Das B, Ray A.
    Eur J Pharmacol; 2006 Sep 18; 545(2-3):167-72. PubMed ID: 16899241
    [Abstract] [Full Text] [Related]

  • 29. Clinical pharmacology of befloxatone: a brief review.
    Rosenzweig P, Patat A, Curet O, Durrieu G, Dubruc C, Zieleniuk I, Legangneux E.
    J Affect Disord; 1998 Dec 18; 51(3):305-12. PubMed ID: 10333984
    [Abstract] [Full Text] [Related]

  • 30. Anxiolytic and memory improving effects of moclobemide.
    Nowakowska E, Chodera A, Kus K, Rybakowski J.
    Arzneimittelforschung; 1998 Jun 18; 48(6):625-8. PubMed ID: 9689417
    [Abstract] [Full Text] [Related]

  • 31. Effect of co-administration of subchronic lithium pretreatment and acute MAO inhibitors on extracellular monoamine levels and the expression of contextual conditioned fear in rats.
    Kitaichi Y, Inoue T, Nakagawa S, Izumi T, Koyama T.
    Eur J Pharmacol; 2006 Feb 27; 532(3):236-45. PubMed ID: 16487506
    [Abstract] [Full Text] [Related]

  • 32. Anxiolytic- and antidepressant-like properties of ketamine in behavioral and neurophysiological animal models.
    Engin E, Treit D, Dickson CT.
    Neuroscience; 2009 Jun 30; 161(2):359-69. PubMed ID: 19321151
    [Abstract] [Full Text] [Related]

  • 33. Antidepressant-like effects of selegiline in the forced swim test.
    Shimazu S, Minami A, Kusumoto H, Yoneda F.
    Eur Neuropsychopharmacol; 2005 Oct 30; 15(5):563-71. PubMed ID: 16139174
    [Abstract] [Full Text] [Related]

  • 34. The effects of moclobemide on the yohimbine-induced anxiogenic action in the elevated plus-maze.
    Eroğlu L, Güven O.
    Pharmacol Res; 1998 Feb 30; 37(2):137-43. PubMed ID: 9572069
    [Abstract] [Full Text] [Related]

  • 35. Monoamine oxidase inhibition and the induction of ponto-geniculo-occipital wave activity by reserpine in the cat.
    Gershon MD, Brooks DC.
    J Pharmacol Exp Ther; 1976 Jun 30; 197(3):556-66. PubMed ID: 6784
    [Abstract] [Full Text] [Related]

  • 36. Antidepressant-like effects of the ethanolic extract of Xiaobuxin-Tang, a traditional Chinese herbal prescription in animal models of depression.
    Zhang YZ, Li YF, Yu NJ, Yuan L, Zhao YM, Xiao WB, Luo ZP.
    Chin Med J (Engl); 2007 Oct 20; 120(20):1792-6. PubMed ID: 18028773
    [Abstract] [Full Text] [Related]

  • 37. [The comparative influence of pyrazidol, inkazan and other antidepressant monoamine oxidase inhibitors on the pressor effect of tyramine].
    Andreeva NI, Golovina SM, Faermark MF, Shvarts GIa, Mashkovskiĭ MD.
    Farmakol Toksikol; 1991 Oct 20; 54(2):38-40. PubMed ID: 1884793
    [Abstract] [Full Text] [Related]

  • 38. Antidepressant-like profile and MAO-A inhibitory activity of 4-propyl-2H-benzo[h]-chromen-2-one.
    Vergel NE, López JL, Orallo F, Viña D, Buitrago DM, del Olmo E, Mico JA, Guerrero MF.
    Life Sci; 2010 May 22; 86(21-22):819-24. PubMed ID: 20394758
    [Abstract] [Full Text] [Related]

  • 39. [Hypertensive crises with reversible inhibitors of monoamine oxidases? Results of tyramine interaction studies].
    Bieck PR.
    Psychiatr Prax; 1989 Aug 22; 16 Suppl 1():25-31. PubMed ID: 2587674
    [Abstract] [Full Text] [Related]

  • 40. Anxiolytic-like effect of linezolid in experimental mouse models of anxiety.
    Jindal A, Mahesh R, Kumar B.
    Prog Neuropsychopharmacol Biol Psychiatry; 2013 Jan 10; 40():47-53. PubMed ID: 23021974
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 23.